| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0508 |
| Document Type: 4 |
| Period of Report: 3/25/24 |
| Issuer: |
| Issuer CIK: 1070494 |
| Issuer Name: ACADIA PHARMACEUTICALS INC |
| Issuer Trading Symbol: ACAD |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1816160 |
| | Owner Name: Kihara James |
| Reporting Owner Address: |
| | Owner Street 1: C/O ACADIA PHARMACEUTICALS INC. |
| | Owner Street 2: 12830 EL CAMINO REAL, SUITE 400 |
| | Owner City: SAN DIEGO |
| | Owner State: CA |
| | Owner ZIP Code: 92130 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: PRINCIPAL ACCOUNTING OFFICER |
| | Other Text: |
| Aff 10b5 One: 0 |
| Non-Derivative Table: |
| Derivative Table: |
| Derivative Transaction: |
| | Security Title: |
| | | Value: Stock Options (Right to Buy) |
| | Conversion or Exercise Price: |
| | | Value: 17.84 |
| | Transaction Date: |
| | | Value: 3/25/24 |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 13,964 |
| | | Transaction Price Per Share: |
| Value: 0 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Exercise Date: |
| | | Footnote ID: F1 |
| | Expiration Date: |
| | | Value: 3/24/34 |
| | Underlying Security: |
| | | Underlying Security Title: |
| Value: Common Stock |
| | | Underlying Security Shares: |
| Value: 13,964 |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 13,964 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| | | Nature of Ownership: |
| Value: |
| Derivative Transaction: |
| | Security Title: |
| | | Value: Restricted Stock Units |
| | Conversion or Exercise Price: |
| | | Footnote ID: F2 |
| | Transaction Date: |
| | | Value: 3/25/24 |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: A |
| | | Equity Swap Involved? No |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 8,568 |
| | | Transaction Price Per Share: |
| Value: 0 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Exercise Date: |
| | | Footnote ID: F3 |
| | Expiration Date: |
| | | Footnote ID: F3 |
| | Underlying Security: |
| | | Underlying Security Title: |
| Value: Common Stock |
| | | Underlying Security Shares: |
| Value: 8,568 |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 8,568 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| | | Nature of Ownership: |
| Value: |
| Footnotes: |
| Footnote - F1: 25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter. |
| Footnote - F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| Footnote - F3: The restricted stock units vest in four equal annual installments beginning March 25, 2025. |
| Owner Signature: |
| Signature Name: /s/ Jennifer J. Rhodes, Attorney-in-Fact |
| Signature Date: 3/27/24 |
